Local view for "http://purl.org/linkedpolitics/eu/plenary/2010-09-22-Speech-3-966"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2010-09-22"^^xsd:date2
dcterms:Is Part Of	lp_eu:Explanations of vote2
dcterms:Language	"pt"^^xsd:language2
lpv:document identification number	"en.20100922.20.3-966"2
lpv:hasSubsequent	lp_eu:2010-09-22-Speech-3-9652
lpv:speaker	lp:Nuno Melo2
lpv:spokenAs	member_of_the_bureau; EPP (2009-07-14--2014-06-30)3 member; LIBE (2009-07-16--2012-01-18)3 vice-chair; Delegation for relations with the Mercosur countries (2009-09-30--2014-06-30)3 substitute; Delegation for relations with the Palestinian Legislative Council (2009-09-16--2014-06-30)3 substitute; DROI (2009-07-16--2012-01-18)3 unknown; Partido Popular (2009-07-14--2014-06-30)3 substitute; ECON (2009-07-16--2012-01-18)3 member; Delegation to the Euro-Latin American Parliamentary Assembly (2009-09-16--2014-06-30)3
lpv:translated text	"The pharmaceutical industry is one of the most important sectors in today’s societies, at an economic, social and scientific level. The EU is no exception, and this sector provides it with a source of economic growth and sustainable employment, besides contributing to the general welfare of the European public. However, in spite of the existing legislation, it is estimated that there are approximately 197 000 deaths in the EU every year caused by adverse reactions to medicinal products. Given these premisses, it is vital that there is consistent, sound and sector-oriented legislation. As the prime objective of this proposal is to improve the information provided to the public about the medicinal products taken and their respective side-effects, and bearing in mind that a good overall agreement has been achieved regarding the amendments to the initial proposal, I agree with the new measures adopted. Ultimately, these are an added value that means practical solutions for the consumer."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph